Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury.

Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury. Oncotarget. 2018 Oct 09;9(79):34857-34858 Authors: Mizrahi JD, Overman MJ PMID: 30405879 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30405879?dopt=Abstract

Source: Oncotarget - November 9, 2018 Category: Cancer & Oncology Tags: Oncotarget Source Type: research

More News: Avastin | Eloxatin